Definitive Healthcare announces changes to Board of Directors
Definitive Healthcare (Nasdaq; DH) announced Sastry Chilukuri joined the Board of Directors and Randy Winn departed.
Definitive Healthcare to present at the 2022 Baird Global Healthcare Conference and the 2022 Goldman Sachs Communacopia + Technology Conference
Definitive Healthcare (Nasdaq: DH) will present at the 2022 Baird Global Healthcare Conference and the 2022 Goldman Sachs Communacopia + Technology…
Definitive Healthcare wins gold in the 2022 Stevie Awards for Great Employers
Definitive Healthcare has been named the winner of a Gold Stevie Award® in the seventh annual Stevie Awards for Great Employers.
Definitive Healthcare wins 2022 Medigy HITMC Award for Video of the Year
Definitive Healthcare was named a 2022 Medigy HITMC Award Winner for a video celebrating the launch of its Latitude Reporting product.
Definitive Healthcare reports financial results for second quarter fiscal year 2022
Definitive Healthcare (Nasdaq: DH) announces financial results for the quarter ended June 30, 2022.
Definitive Healthcare to present at the Canaccord Genuity 42nd Annual Growth Conference
Definitive Healthcare (Nasdaq: DH) will present at the Canaccord Genuity 42nd Annual Conference on August 10, 2022.
Definitive Healthcare wins three Stevie® American Business Awards® for customer service
Definitive Healthcare was named a winner of three Stevie® Awards in the 20th Annual American Business Awards®.
Definitive Healthcare wins Energage 2022 Top Workplaces Culture Excellence Awards
Definitive Healthcare wins Energage 2022 Top Workplaces Culture Excellence Awards.
Definitive Healthcare launches Passport Express to provide ready-to-use healthcare commercial intelligence for biopharma
Definitive Healthcare announced the general availability of Passport Express, the newest product in the Passport Analytics Suite.